Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:45 AM
Ignite Modification Date:
2025-12-25 @ 2:45 AM
NCT ID:
NCT05998733
Eligibility Criteria:
Inclusion Criteria:
* Time from clinical symptoms to admission ≤ 7 days；
* infection was diagnosed by clinician
* Systemic inflammatory response syndrome，Systemic inflammatory response syndrome was defined as the presence of 2 or more of the following: (1) temperature \<36℃or \>38℃, (2) heart rate \>90 beats per minute, (3) respiratory rate \>20 breaths per minute or PaCO2 \< 32 mm Hg, or (4) white blood cell count ≥12 000 cells/mm3 or≤4000 cells/mm
Exclusion Criteria:
* Pregnancy and lactation
* Have hematological diseases (including acute and chronic leukemia, hemolytic anemia, hemophilia, aplastic anemia, bone marrow fibrosis, congenital or acquired coagulation factor deficiency, etc.)
* Anticoagulant or antiplatelet drug treatment
* 24 hours after severe trauma or surgery
* Autoimmune diseases
* cirrhosis
* Malignant tumor patients with personal history or undergoing radiotherapy, chemotherapy and targeted treatment
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
90 Years
Study:
NCT05998733
Study Brief:
Protocol Section:
NCT05998733